Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic-Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK InhibitorWONG, Harvey; VERNILLET, Laurent; HOEFLICH, Klaus P et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3090-3099, issn 1078-0432, 10 p.Article

SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsFORSYTH, Timothy; KEARNEY, Patrick C; EPSHTEYN, Sergey et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7653-7658, issn 0960-894X, 6 p.Article